NCT00952263View on ClinicalTrials.gov

Study in Healthy Volunteers to Evaluate a Human Monoclonal Antibody Against Hepatitis C

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Healthy

Interventions

BIOLOGICAL

MBL-HCV1

Single infusion of MBL-HCV1 at escalating doses as determined by cohort assignment: Cohort 1 @ 1 mg/kg, Cohort 2 @ 3 mg/kg, Cohort 3 @ 10 mg/kg, Cohort 4 @ 30 mg/kg, Cohort 5 @ 50 mg/kg.

Trial Locations (1)

55404

DaVita Clinical Research, Minneapolis